My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Deus Medical Deus Medical
EPO
EPO - Deus Medical

EPO - Deus Medical

Brand:
Deus Medical
Category:
Peptides
Substance:
Erythropoietin
Package:
3000 iu
Price:
$0.00 - $0.00
See options
Product Overview

Erythropoietin (EPO) is a synthetic option of a hormone naturally produced by the human body that controls the production of red blood cells. It was authorized for medical purposes in 1984 to treat anemia resulting from chronic kidney disease and cancer therapies. Athletes in sports commonly utilize EPO to enhance their endurance by elevating the bloods ability to carry more oxygen through a rise in the count of blood cells.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about EPO by Deus Medical, consult with your doctor or healthcare professional.

Products
Active Substances
  • Erythropoietin
Common Names
  • EPO
 About Product
EPO
Deus Medical
Europe
$0.00
Info
Show more
Explore More Products
Reviews
Leave Review
FAQ
When was Erythropoietin first discovered?
In the 20th century scientists discovered erythropioetin and delved into extensive studies to unravel its function in the production of red blood cells.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Who played a key role in the development of EPO for clinical use?
Scientists, at Amgen in the 1980s played a role, in pioneering the development of epogen alfa ( EPO) which greatly enhanced its medical uses.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What important events signified the acceptance of Erythropioetin, for application in healthcare settings?
Erythropoitin was granted authorization by the FDA in 1989 which marked an advancement in managing anemia challenges faced by individuals, with chronic kidney disease and cancer patients alike.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.